2024年12月4日 · BAVENCIO (avelumab) Injection is a sterile, preservative-free, and clear, colorless to slightly yellow solution for intravenous infusion supplied as a single-dose vial of …

BAVENCIO ® (avelumab) is indicated for: The treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC) The maintenance treatment of patients …

Bavencio Injection is a type of immunotherapy. It activates the body's immune system to fight cancer cells. Avelumab targets and blocks a protein (PD-L1) found on the surface of certain …

2025年3月1日 · Avelumab injection is used to treat a kind of skin cancer called Merkel cell carcinoma (MCC) that has spread. Avelumab injection is also used to treat urothelial …

BAVENCIO (avelumab) is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). This indication is approved under...

2025年1月9日 · Bavencio (avelumab) injection is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults and pediatric patients 12 years and older with …

Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). …

What is avelumab? Avelumab is used to treat a type of skin cancer called Merkel cell carcinoma in adults and children at least 12 years old, when the cancer has spread to other parts of the …

Avelumab injection is used to treat Merkel cell carcinoma (MCC; a type of skin cancer) that has spread to other parts of the body in adults and children 12 years of age and older.

Avelumab is a programmed death-ligand 1 (PD-L1) blocking human IgG1 lambda monoclonal antibody. This is the first FDA-approved product to treat this type of cancer.